Medline (MDLN) Signs First Prime Vendor Agreement with Mohawk Medbuy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Medline's Prime Vendor model expands outside the United States
May 29, 2026 10:26 AM EDTAgreement with Mohawk Medbuy in Canada marks first-of-its-kind Prime Vendor relationship outside the U.S.
NORTHFIELD, Ill., May 29, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) announced that Medline... More
Medline Inc. announces closing of upsized secondary offering of Class A common stock
May 28, 2026 4:30 PM EDTNORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (Medline) announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the Selling Stockholders) at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medlines Class A common stock.
... MoreMedline announces participation in upcoming investor conferences
May 27, 2026 7:30 AM EDTNORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Medline) (Nasdaq: MDLN) today announced that members of the executive leadership team will be participating in the following investor conferences.
Mike Drazin, chief financial officer, and Amanda Laabs, chief product officer, are scheduled to present at the William Blair 46th Annual... MoreMediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 27, 2026 7:00 AM EDTEscharEx® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027
First quarter revenue of $1.5 million; full-year 2026 revenue guidance reaffirmed at $24-26 million
Conference Call Today, May 27, 2026, at 8:30 a.m. Eastern Time
YAVNE, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the first quarter ended March 31, 2026, and provided a corporate... More
